Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Natera, Inc. Director's Dealing 2025

Mar 20, 2025

30253_dirs_2025-03-19_02004055-660c-4f1d-a51d-2f2d031bee9d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Natera, Inc. (NTRA)
CIK: 0001604821
Period of Report: 2025-03-17

Reporting Person: Sheena Jonathan (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-03-17 Common Stock S 181 $146.0277 Disposed 261019 Direct
2025-03-18 Common Stock S 2017 $145.1746 Disposed 259002 Direct
2025-03-18 Common Stock S 53 $145.60 Disposed 258949 Direct
2025-03-18 Common Stock S 630 $146.8148 Disposed 258319 Direct
2025-03-18 Common Stock S 1070 $145.0942 Disposed 42212 Indirect
2025-03-18 Common Stock S 430 $146.7827 Disposed 41782 Indirect
2025-03-18 Common Stock S 1010 $145.2119 Disposed 42272 Indirect
2025-03-18 Common Stock S 490 $146.7767 Disposed 41782 Indirect

Footnotes

F1: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on March 12, 2025.

F2: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2023.

F3: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.55 to $145.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.78 to $147.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.

F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.55 to $145.43 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.78 to $146.79 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.67 to $145.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.40 to $146.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.